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Life Sciences and Health in South West Wales: A sub-regional innovation ecosystem 
Gareth Huw Davies, Robert Marc Clement, Louisa Huxtable-Thomas, George Johnson, Brian 
Perkins, Sian Roderick, Jennifer Gregory, Bjorn Max Rodde and Jayne Daniels  
Abstract       
South Wales has been nurturing a nascent Life Sciences cluster through initiatives including 
the Institute of Life Science (ILS) at Swansea University Medical School. ILS aims to 
provide an entrepreneurial learning environment transcending industry, healthcare, academia 
and further education. This chapter describes how efforts to develop the sector have been 
undertaken through structured efforts of Understanding, Acting and Measuring, resulting in 
new ventures formed through spin-outs to commercialise research output and collaboration 
with other enterprises. Building upon concepts of clustering and regional innovation systems, 
the approach demonstrates the harnessing of a long-term strategy involving smart 
specialisation resulting in emerging and meaningful economic impact. Networking and 
knowledge exchange are shown as core components of a system reaching across wider 
sectors involving a diversity of skills. The conclusions demonstrate how entrepreneurial 
learning has also helped develop further actions including Talent Bank in support of the 
region’s broader ambition of A Regional Collaboration for Health (ARCH). 
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1. Introduction 
  
1.1 South West Wales 
 
South Wales has long been nurturing a nascent Life Sciences cluster (DTI 2001) and has 
looked to develop the potential of the sector as part of a wider strategy for economic renewal 
(WAG 2005, WAG 2010). Significant investments by public and private sectors have 
established a substantial research infrastructure and new enterprise, much of it focused 
around the Swansea Bay City region and involving Swansea University’s Medical School.  
Most recently, regional efforts to develop the sector have focused upon ‘smart specialisation’ 
strengths including medical devices, informatics and wound healing. Entrepreneurial learning 
sits at the heart of these endeavours, working to commercialise academic research and 
enhance industrial collaboration. This chapter records how these efforts have been involved 
in the development of a Life Sciences and Health cluster within a sub-regional innovation 
system/ecosystem involving enterprises from a broad range of sectors.   
This development is presented through Understanding: the insight established to inform 
interventions for sector development; Acting: efforts undertaken to create new enterprise with 
support of the Medical School; Measuring: and a summary of the impact it has had upon the 
regional economy.  
1.2 Industrial History 
 
The current dynamics of economic development in South West Wales can be traced back to 
the economic restructuring that saw the United Kingdom established as the world’s first 
industrial nation (Mathias 2013). This revolution continued with subsequent contraction of 
the steel industry and the almost complete disappearance of the coal industry during the 
1970s and 1980s, punctuating a trend of economic decline that had set in during the post-war 
period (Morgan 2001). 
Subsequently, economic development policy in Wales has focused on pursuing inward 
investment with what Cooke and Clifton (2005) termed a ‘field of dreams’ approach of ‘build 
it and they will come’. This produced significant impact (Braczyk, Cooke et al. 1998) 
(Salvador and Harding 2006) particularly during 1983-93, with Wales attracting 15-20% of 
inward-UK Foreign Direct Investment (FDI). One major investment could deliver significant 
employment to the surrounding region and much like the iron works of old could become the 
prime employer in a town or region.  
However, this FDI revolution turned further as opportunities declined during the 1990s with a 
slowing UK economy (Young, Hood et al.) and emergence of competitor regions such as 
China and India (Chen 1996). This resulted in some overseas-managed manufacturing branch 
plants relocating from Wales to regions with lower cost bases, with impacts on communities 
similar to the pit closures previously experienced. Observers noted weaknesses in the 
‘embeddedness’ of such activity (Phelps, Mackinnon et al.), together with imbalance in the 
focus given to indigenous enterprise and clusters (Cooke and Clifton 2005).  
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1.3 Knowledge Economy 
 
The ambition to transform the Welsh economy to one with a greater capacity for Research & 
Development and Innovation was set over a decade ago by the Welsh Assembly Government 
with A Winning Wales (WAG 2004b). Actions stemming from this strategy included 
implementation of an Entrepreneurship Action Plan and a fund to develop new ventures from 
the output of university research. Much focus was given to Information Communication 
Technology (ICT) and ‘Green’ sectors, though with wider efforts to support new and existing 
growth sectors and clusters.    
 
During this period Cooke, Kaufmann et al. (2006) described the emergence of Regional 
Science Policy that the Welsh Government (WG) came to with its strategic agenda, Science 
for Wales (WAG 2009). This placed ‘Life Sciences and Health’ as a Grand Challenge area to 
be tackled though the EU approach of Smart Specialisation, and the associated concentration 
of investment into excellence. Programmes such as Sêr Cymru (providing funding to attract 
leading researchers) and the restructuring of the Health and Care Research Wales Research 
Infrastructure have stated the intention to build capacity and maximise impact. This approach 
provides a mix of industry and cluster policy development objectives discussed at the time by 
Cooke (2004a), and more recently by Ketels (2013), with knowledge transfer and 
commercialisation core components of the strategy. The inherent complexity, long-term 
nature and the fact that meaningful impact of such endeavours may not be seen for years after 
initial investment have been noted by Huggins and Kitagawa (2012). This is especially 
important for a sector where innovations can require years, or even decades, of effort.  
More recently the Welsh Government’s (WG) strategy for economic development has 
become more sector focused, and is aimed towards nine key sectors, including Life Sciences, 
which it recognises as being particularly important for its additional health and broader 
societal benefits; 
“The Life Sciences sector is an important driver of economic growth and improved 
well being. It serves large global markets which are growing quickly, driven 
especially by population growth, changing demographics and increasing expectations 
from medicine and therapy” (WG 2013) p.18 
WG has established a sector panel to develop and implement a strategy and action plan to 
harness the potential of Life Science for Wales as a whole with the vision “to facilitate the 
growth of a dynamic life science ecosystem, leveraging financial investment where industry, 
academia, clinicians and government collaborate and deliver a sustainable economy and 
excellence in healthcare innovation” (WAG 2014). To achieve this vision, WG has embarked 
upon a number of strategic initiatives including notable investments to build upon strengths 
across the sector. The attraction of talent, and development of indigenous knowledge and 
intellectual property are central to two of the major pan-Wales interventions of the Arthurian 
Investment Fund and Sêr Cymru.   
1.4 Life Sciences in Wales 
In 2001, the UK Department for Trade and Industry (DTI 2001) identified a nascent 
biotechnology cluster within Wales. Although this did not appear in the 31 key UK clusters 
described in the more recent McKinsey (2014) review, it is seen in subsequent analysis by 
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consultants (SQW 2014) this also applied to many clusters identified in 2001 by DTI, 
including ones that had grown during the intervening period.   
In parallel with this observation, although not explicitly targeted in the Welsh Assembly 
Government Economic Development Strategy, A Winning Wales (WAG 2004a), the sector, 
defined as ‘pharmaceuticals/bio-chemicals’ was identified as important for future economic 
growth (WAG 2005). 
Active Enterprises by Priority Sub-Sector - Life Sciences1,2,3
2005 2006 2007 2008 2009 2010 2011 2012 2013
% of 2013 
total
Change 
2005 - 2013
Change 
2012 - 2013
Wales:
Industrial Biotechnology 35 35 35 40 35 30 25 25 20 7.3% -38.9% -12.0%
Medical Biotechnology 95 100 105 150 130 120 120 110 110 40.0% 13.7% -1.8%
Medical Technology 115 110 110 110 110 110 95 100 100 36.4% -12.9% 0.0%
Others (inc Pharmaceuticals) 25 25 25 25 30 30 30 40 45 16.4% 80.4% 12.5%
Total Life Sciences 270 270 275 325 305 285 270 275 275 100.0% 1.6% 0.0%
UK:
Industrial Biotechnology 460 450 460 435 400 360 335 330 345 5.2% -25.0% 4.2%
Medical Biotechnology 2,490 2,605 2,690 3,300 3,175 3,090 3,015 2,980 2,955 44.3% 18.7% -0.8%
Medical Technology 2,405 2,380 2,380 2,180 2,385 2,320 2,300 2,305 2,345 35.2% -2.6% 1.6%
Others (inc Pharmaceuticals) 540 545 550 490 625 675 755 895 1,020 15.3% 89.3% 13.8%
Total Life Sciences 5,895 5,975 6,080 6,405 6,585 6,450 6,410 6,515 6,665 100.0% 13.1% 2.3%
Source: Inter-Departmental Business Register, Office for National Statistics  
Table 1: Life Sciences Enterprises by Subsector 
 
Employing 10,000 people across Wales and annually contributing £2bn to the economy 
(WAG 2014), the Welsh Life Sciences sector is developing rapidly, particularly in 
comparison to other sectors which have suffered badly during recent years. In Wales, the 
sector has seen significant investment and growth including a number of major regional 
developments. This has resulted in growth in Gross Value Added (GVA) of circa 13% per 
annum across the sector despite the chronic broader economic conditions (Table 1 above).  
Over 80% of sector employment is within medium/large enterprises. However the Welsh 
‘ecosystem’ also comprises scores of smaller companies and sole traders, many of whom are 
also globally active. While the South East of England accounts for the largest share of the 
sector there are strengths across the UK, including within Wales a significant proportion of 
medical technology activity (Table 1). The comparative strength of this sub-sector is 
highlighted when compared in more detail against other UK regions (see Fig. 1 below). 
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The regional diversity within the sector ranges from global companies manufacturing medical 
supplies such as Ortho Clinical Diagnostics, through to indigenous enterprises such as Biotec 
Services International providing specialist clinical trials supplies and support.   
The relatively low showing for the pharmaceutical sub-sector in Wales suggested by Figure 1 
hides a mass of associated activity in clinical trials, drug discovery and toxicology research 
which is featured elsewhere. Indeed, the quality of work across Wales in the development of 
new diagnostics and therapies is world-class. For example, Cell Therapies Ltd, a start-up 
founded by a Nobel Prize Winner for Medicine, has undertaken part of its development work 
both in Cardiff University and Swansea University’s Institute of Life Science.  
The ‘South West and Central Wales’ region is home to a diverse Life Sciences enterprise 
ranging from early-stage academic spin-outs through to major employers producing products 
for household names. ILS for example works with some 250 enterprises ranging from local 
specialist consultants through to multinationals. While the regional employment within core 
Life Science is the smallest amongst Welsh Government Priority Sectors, its high GVA per 
worker, significant growth potential and crossover with other high-value sectors are 
important drivers.   
1.5 Institute of Life Science (ILS) 
The Institute of Life Science1 has been developed as a partnership between Swansea 
University’s Medical School, Abertawe Bro Morgannwg University Health Board 
(ABMUHB), Welsh Government (WG) and the private sector to develop the potential of Life 
Science research and innovation to help improve the wealth and health of Wales. These 
efforts have been combined with broader WG efforts to build a Life Science ‘Ecosystem’.  
This initiative aims to help address regional limitations in regional innovation capacity 
including the comparatively low level of Business Expenditure on Research and 
                                                          
1 http://www.swansea.ac.uk/ils/ 
Fig. 1:  Sub-sector employment by region – Source: (Govt 2014) 
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Development (BERD) and the requirement for new opportunities and ventures to support 
sector development. This underscores the importance of local higher education institutions 
noted in the WG Knowledge Economy Nexus review of the interplay between Welsh higher 
education and industry (WAG 2004b).   
Since 2004, the ILS initiative has created a number of facilities including biomedical 
laboratories, a dedicated clinical research facility, a medical imaging research suite, and 
business incubation/growth. Co-located with clinical facilities and expertise of the ABMUHB 
Singleton Hospital site and the wider academic resources of Swansea University, ILS is 
supported by a team engaged in commercialisation of research and development of other 
industrial collaborations. In this respect ILS has aimed to create an entrepreneurial learning 
environment where the boundaries of academia, industry, health service and other actors 
innovate together.   
The ILS facilities have been realised through £37.9m of investment from Welsh Government 
and European Structural Funds (via European Union Objective One and Convergence 
Programmes), with the technology transfer and research activities sustained through 
reinvestment of research and commercial incomes. Capabilities, such as ILS, aim to provide 
intellectual output to support regional sector development. This, however, needs to be aligned 
with the ‘absorptive capacity’ of firms and the broader industrial sector within the region to 
harness this for its benefits to be captured locally.  In essence, this requires an alignment 
between the existing and growing sectors to optimise the impact of university output and 
wider relevant interventions. The next section describes efforts undertaken to develop this 
Understanding, to inform strategy and delivery of actions including the Institute of Life 
Science.    
2. Understanding:  
 
2.1 Regional Learning Partnership/Life Science Exchange  
 
Vibrant sustainable knowledge-driven clusters have been demonstrated as drivers of 
productivity and innovation (Porter 2000) and engines of new venture formation (Delgado, 
Porter et al. 2010), so an interest in them from policy-makers for economic development is 
understandable. However, research into Life Sciences clusters has often focused on major US 
and EU clusters (Cooke 2004a), and there exists some scepticism of the effectiveness of 
interventions for their development (Martin and Sunley 2003) (Brakman and van Marrewijk 
2013). A core concern has been ‘fuzziness’ of the cluster concept, while other commentators 
acknowledge the gap between theory and practice (Swords 2013), and the need for a 
consideration of specific local context (Ketels 2013).  
Recent regional efforts have provided important learning for future development with a 
review of interventions noting limitations in absorptive capacity (Cooke 2004b) and loss of 
focus upon the knowledge-economy mission (Morgan 2013). To help address the issues 
identified, detailed understanding of the sector has been developed, through the work of the 
Regional Learning Partnership (RLP) and MediWales. This has involved the surveying and 
interviewing of diverse sector companies in the region, along with focus groups examining 
key sub-sectors. The intention of this work has been to use the insight gained to resolve the 
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challenge of ‘fuzziness’ in the concepts involved, and deliver both regional and sector-
specific perspective in tailoring interventions attuned to absorptive capacity     
2.2 Regional Learning Partnership (RLP) Survey 
The purpose of the RLP report was to scope and understand the ‘Skills Pipeline’ into the 
regional Life Sciences sector. The inherent lead time of affecting major change within a 
regional skills base is a significant challenge in supporting the development of rapidly 
developing sectors such as the Life Sciences. This is underlined by the fact that secondary 
school pupils currently making important subject choices may not enter the labour market for 
a decade, if they continue through into further and higher education. Furthermore, the 
complexity of the sector, overlapping into ICT, Advanced Manufacturing and other Services 
required broad consideration of the skills involved. 
The research was undertaken to provide recommendations to assist the region in optimising 
its provision and subsequent benefit from the skill base required to harness the potential of 
the sector. The study underpinning the report involved analysis of the current supply of 
qualified individuals from schools, further education and higher education institutions, 
together with a survey of enterprise needs across the sector.   
The RLP research involved a detailed survey and interviewing of a representative forty-six 
enterprises across the region. Alongside the skills and workforce aspects of the research, the 
research and development (R&D), innovation and networking activities of companies were 
also surveyed to provide a more detailed understanding of the dynamics involved. 
 While relatively small, this survey highlighted a number of key issues, not least the 
interdependence between Life Sciences and other sectors across the region. With respect to 
roles within companies, a significant proportion of Life Sciences employment related to 
‘manufacturing’ roles (Table 2).  
Sub-Sector / 
Roles 
Number of 
companies 
Technical 
Roles 
(FTE) 
Managerial 
Roles 
(FTE)  
Administrative 
Roles (FTE) 
‘Other’ 
Roles 
(FTE) 
Medical Devices  18 46.8 49.3 46.3 94.3 
Specialist Services 10 34 17 11 6 
Human 
Therapeutics 
6 49 15 17 2 
Manufacturing 8 93.8 60.3 60.1 173.7 
Veterinary/Enviro
nmental 
1 0 1 1 0 
Clinical Research 3 58 29 26 1 
Other 12 47 14 12 16 
Table 2  Employment breakdown by sub-sector 
 
While the findings summarised in Table 2 demonstrate the medical technology nature of the 
sector within the region, it also points encouragingly to the fact that there are enterprises with 
their entire value chain from basic R&D through to manufacturing and distribution within the 
region. This is discussed further in the following section.  
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Much focus is understandably given to the specialist scientific skills required to support 
R&D, and this provides an important linkage between the sector and academic institutions.  
However, as shown in Table 3, presenting planned recruitment by surveyed companies, the 
majority of roles fall outside of this scope. While this provides a broader challenge for skills 
supply, it also highlights the wider employment potential for the sector beyond Science, 
Technology, Engineering, Mathematics, and Medicine (STEMM)-trained individuals.  
Sector Technical Managerial Administrative Other Total 
Medical Devices 16.25 11.17 11.78 8.00 47.20 
Specialist services 2.00 0.40 0.80 1.50 4.70 
Human 
Therapeutics. 
12.75 5.37 3.38 0.00 21.50 
Manufacturing 4.25 2.18 2.67 1.00 10.10 
Veterinary/Enviro
nmental 
0.50 0.50 0.50 0.50 2.00 
Clinical Research 4.75 2.38 1.37 0.00 8.50 
Other 7.00 0.00 3.00 9.00 19.00 
Total 47.5 22 23.5 20 113 
Table 3 Anticipated recruitment breakdown by sub-sector 
The Report’s recommendations included the establishment of a group to support the sector, 
together with specific actions aimed across further and higher education, schools and other 
stakeholders. Such a group has since been established as the All Wales Life Sciences Skills 
Group, with strong regional involvement and engagement with Welsh Government’s 
departments of Economy, Science & Transport, and Education & Skills. A key response to 
the Report’s recommendations has been the development of the ‘Talent Bank’ in partnership 
between Gower College (further education) and Swansea University’s Medical School. The 
concept involves the creation of a dedicated Life Sciences and Health FE College co-located 
with the University, Health Boards and industry. Intensified curricula informed and delivered 
in partnership with practitioners are intended to support skills supply from for students aged 
16 to18 through to continuing professional development as part of an integrated sector-
focused lifelong learning system.  
2.3 Life Science Exchange 
Alongside the RLP research, wider actions have been taken to understand the dynamics and 
opportunities of the regional sector, a prime example of which is Life Science Exchange 
(LSE)2. The aim of LSE was to identify and develop academic, public and private sector 
knowledge exchanges that effect economic change. The LSE work has involved a series of 
‘sandpits’ (events bringing together experts from a range of disciplines/sectors to explore a 
specific topic or problem space)  and quarterly focus groups examining specialist areas of 
diagnostics, ehealth, medical technology, neuroscience, pharmaceuticals, and regenerative 
medicine, aligning with the identified Welsh smart specialisations. This created sub-sector-
specific entrepreneurial learning groups that has informed understanding and in itself has 
provided a learning environment for participants.  
                                                          
2 http://www.swansea.ac.uk/life-science-wales/ 
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The output of the Life Science Exchange is a body of sector intelligence that represents the 
collective expertise of a wide range of expert contributors. This purpose of the work is to 
inform future policy and planning across the sector and will help to align support activities 
with the needs of companies, universities and health care providers. Specific, actionable 
recommendations have been provided in the detailed reports provided by the Life Science 
Exchange to the WG with the ultimate aim of improving innovation, health, and wealth in 
Wales. 
The work has highlighted the important role of the Welsh National Health Service (NHS) in 
providing access to clinical expertise, facilities, and ultimately as a customer. Opportunity for 
greater engagement and clinical access for R&D was noted, along with scope for greater 
evaluation and adoption of Welsh innovations. 
There was a recognised need for the engagements instigated by the Life Science Exchange to 
continue into the future. In some cases, specific challenges and opportunities needed to be 
crystallised into detailed proposals with specific objectives, deliverables, budgets and time-
scales. A number of organisations have expressed the desire to maintain the momentum of 
their respective focus groups as Special Interest Groups operating under the Life Science 
Exchange brand or unique branding (e.g. Clinical Trials Services Wales). 
The Life Science Exchange process has brought together hundreds of stakeholders in a sub-
sectoral approach to the Welsh National Innovation System. This has resulted in a multitude 
of collaborations, projects, inward investment opportunities, and special interest group 
formations, in addition to securing multiples of investment in funding for Wales. There was a 
view found amongst participants that processes such as the Life Science Exchange should be 
continued to be supported by the WG and the process could be held up as a shining example 
of best practice for knowledge exchange for other sectoral systems of innovation. The Life 
Science Exchange model is a simple and straightforward mechanism for any regional 
government to adapt and implement with the hope of improving innovation, skills, networks 
and knowledge exchange. 
3. Acting: Institute of Life Science  
 
3.1 ILS Overview 
Since its inception in 2004, ILS has established research and innovation capacity to assist in 
developing a regional cluster built from enterprise including academic spin-outs, existing and 
new indigenous enterprise, and inward investment. The focus of the ILS Phase 1 (2004-2008) 
project was to provide specialist medical research laboratories along with business incubation 
facilities to support academic-industrial collaboration. This coincided with the development 
of a research focus in health and bio-informatics underpinned by the IBM Blue-C 
supercomputer infrastructure. Phase 2 (2009-15) involved the development of an expanded 
research infrastructure and incubation capacity, including a clinical research facility, medical 
imaging suite and informatics research offices. 
Alongside the insight from the RLP research and other efforts, ILS has recognised 
weaknesses noted in previous regional initiatives by commentators. Thereby it can be seen as 
trying to learn from experience through ‘experimentalism’ of the form described by 
(Henderson 2000). Efforts have been made to optimise absorptive capacity by aligning an 
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R&D focus with the sector in the region to address challenges noted by Cooke (2004b), while 
more robust management maintains the focus of mission and monitoring, in response to 
issues noted by Morgan (2013).  
The apparent lack of involvement by Technium (a regional initiative to develop a network of 
innovation centres) with the wider innovation system actors, such as financiers, patent 
attorneys and business development specialists identified by Cooke (2004b), has led to ILS 
actively pursuing engagement from the outset, as noted in the following section. This sought 
to create systemic linkages across the sector within the region, nurturing new and supporting 
existing indigenous enterprise while attracting inward-investing opportunities. Examples of 
this include the ‘Scinapse’3 partnership providing professional services and a sector-specific 
cohort of the LEAD Wales initiative4. Both programmes support the entrepreneurial learning 
agenda, with the former providing leading expertise to support businesses, and the latter 
developing leadership within SMEs to promote sustainability and growth.   
The nature of engagement with ILS, both for existing companies and start-ups relates 
significantly to scientific expertise and specialist facilities, as shown in Figure 2 from Davies 
et al., Huxtable-Thomas et al. (2015 ) citing survey and project monitoring data.  
 
Fig. 2: ILS support uptake by engaged existing enterprises and start-ups 
However, the predominant nature of engagement with ILS has been to support networking 
amongst enterprises, researchers and other actors suggesting ILS is playing a more complex 
role within a system rather than having simply separate bipartite relationships with supported 
companies. The involvement of start-up enterprises in such myriad relationships suggests an 
entrepreneurial learning milieu amongst entrepreneurs, academics and other ecosystem 
participants.   
                                                          
3 http://www.lifescienceshubwales.com/members/scinapse/ 
4 http://www.swansea.ac.uk/reis/case-studies/lead-wales/ 
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3.2 ILS Engagement 
The nature of the engagements undertaken by ILS described in the previous section reflect its 
assets and mission, though how this relates to the sector it serves requires further 
consideration to determine whether it is actively supporting development of ‘embeddedness’.   
During the period 2004 to 2013, ILS has worked with 279 enterprises active in the Life 
Sciences and Health sectors across the South West Wales region, with 243 enterprises (87%) 
qualifying as small and medium sized enterprises (SME) based on indicator performance as 
noted in end-project evaluation by The European Consulting Company (TECC)/Trilein June 
2015). This grouping is comparable in scale with the Scottish cluster at the turn of the century 
(Cooke 2001) though with a different nature to its ‘core’.  
These core enterprises span a broad range of segments, with a core of medical technology and 
medical bio-technology reflecting the broader sector in Wales. A recent exercise used an 
adaptation of the Cluster Map developed for Life Sciences in Munich, Germany (Cooke, 
Kaufmann et al. (2006), to present the makeup of enterprises engaged with the cluster around 
ILS (shown in Figure 3 below). This used the same mapping with service providers, 
interrelated industries, supporting organisations and related clusters (as indicated in the key 
for Figure 3). This includes many of the actors seen in the conceptual bioscientific and 
biotechnological value chain proposed by Cooke, Kaufmann et al. (2006). 
 
Figure 3: Regional life sciences and health ecosystem mapping 
The Cluster Map, and the engagement of ILS captures the breadth of organisations within the 
ecosystem. Notable actors include the National Health Service (NHS) (as the Public 
Healthcare System) as a major consumer and partner in the development of Life Science 
innovation; a range of enterprises engaged in various activities in clinical trials; and the role 
of public finance, including the recently established Arthurian Investment Fund.  ILS itself 
features across a number of roles, operating simultaneously as a Research, and Educational 
and Cluster Organisation.  
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The importance of a diversity of actors within the cluster is important for success, though 
with world-class scientific talent as a critical ingredient, as highlighted by Audretsch (2001) 
in a review of US biotechnology clusters as a complementary factor to support 
commercialisation of knowledge. The ILS ecosystem certainly presents such diversity, while 
a recent strong performance of associated researchers in the Research Excellence Framework 
(REF) 20145 and major UK Research Council (RCUK) investments suggest that research 
quality and scale is developing in parallel. 
3.3 Ecosystem enterprise contribution 
The creation of a new enterprise is just one mechanism to develop life science opportunities, 
and most of ILS’s work involves supporting existing enterprises, large and small. However, 
new companies are an important mechanism for commercialising research in an entity 
dedicated to venture and harnessing opportunities within the locale. Indeed, even across 
international borders, start-up opportunities are being actively pursued and poached to embed 
their innovation and job creation potential.    
Start-up enterprises are therefore important, if somewhat longer-term in their impact. Due to 
testing and regulation new ventures commercialising medical products have long lead times, 
typically 10-20 years with new drugs requiring on average $1billion of investment (BIS 
2011). Therefore downstream impacts of new ventures can take a significant time to be 
realised. Therefore for an initiative such as ILS to have a major impact in the near-term 
requires engagement with a broad portfolio of ventures throughout each stage of 
commercialisation. 
To date, assistance provided by the ILS (during the Phase 2 period 2009-15) has resulted in 
the creation of sixteen new enterprises primarily in the fields of medical devices and drug 
discovery. Research suggests that, despite a recent slowing in start-up activity across the 
sector (Mobius 2011) (mainly due to a drop in University spin-outs across the UK), the 
survival and success rates amongst technology firms (excluding those dedicated to specific 
are encouraging. Figure 4 shows the breakdown of ILS start-ups by activity, in comparison 
with the wider community of existing enterprises engaged by ILS.  
 
 
                                                          
5 Research Excellence Framework 2014, www.ref.ac.uk  
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 Drug/ 
Therapeutic 
Device/ 
Technology 
R&D 
Service 
Clinical 
Service 
ILS Engagements 29 73 90 53 
ILS Start-ups 1 8 5 2 
 
Fig. 4.  ILS enterprises assisted and created by segment 
The make-up of the new ventures established through ILS (Fig. 4) presents a diversity 
reflecting the broader regional ecosystem, predominantly based upon medical devices along 
with clinical and other services, while only one enterprise related to pharmaceuticals.  
Interestingly, two of the largest spin-outs each employing over twenty people were 
reincarnations of previous enterprises which had ‘failed’. This emphasises the importance of 
an enlightened entrepreneurial culture which recognises risk, learns from experience, and 
celebrates effort not just success. A further interesting observation from this albeit relatively 
small community is the nature and extents of linkages they possess. Figure 5 shows that 
linkages with external research activities constitute the most prevalent type of linkage. While 
this is to be expected (Mian 1996), it is the relatively high proportion of firms reporting 
multiple linkages which suggests greater embeddedness within the region that suggests a 
clustering effect. This is supported by the fact that just under a third (5/16) firms originated as 
university spin-outs.   
 
Fig. 5 ILS enterprises created: linkages by type 
Recognising, let alone appreciating or understanding, this complexity is a challenge for many 
observers, while the long-lead times and inherent risk of life sciences R&D/innovation 
requires patience and volume to provide likelihood of success.  
The research also highlighted the long-standing finding by Teece (1986) that benefits extend 
beyond the innovating firm. Two of the companies in question had established manufacturing 
relationships with established firms (including a branch plant of a multinational enterprise) in 
the region, resulting in seventy new jobs. Another two companies were in earlier exploratory 
stages of similar arrangements. This finding suggests that the new enterprises are contributing 
to the embeddedness, not only of themselves but also to that of other employers beyond the 
core sector.  
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3.4 Wider engagement: NVI Wales 
The earlier part of this section has shown how ILS has aimed to support the development of 
Life Seciences and Health, with networking within the regional ecosystem supporting an 
entrepreneurial learning ecosystem. However, it should be noted that an internal view of 
activity in the region has been complemented by numerous external engagements to support 
entrepreneurial learning. An example of this is involvement in the National Virtual Incubator 
(NVI) Network. NVI Wales, supported by WG, is part of a flagship initiative of Cisco's 
British Innovation Gateway ("BIG") programme. The NVI network, connects thirteen 
business incubation centres and research institutions around the UK (called ‘NVI Nodes’), 
via state-of-the-art Cisco video conferencing technology. 
 
The purpose of the NVI is to bring organisations together in collaboration to boost levels of 
UK research, innovation and economic growth. NVI is central to the development of the 
UK’s emerging innovation ecosystem. NVI Wales (or the Welsh node) is based in Swansea 
University Medical School at ILS and it joined the network as a specialist communication 
point for life science and ICT start-ups and SMEs.  Entrepreneurs in the Swansea City Region 
and across Wales can visit the Welsh node to connect with other organisations in the UK 
wide network in order to share resources, pool ideas and develop new business partnerships.   
NVI activities include a seminar programme which attracts both UK and internationally 
renowned speakers. These seminars aim to expose businesses in the City Region and the 
national network to the latest technologies and emerging trends. The NVI hosts monthly 
‘Peer to Peer’ sessions which offer local businesses the opportunity to talk to peers from 
across the UK.  Topics covered range from Big Data, Gaming and Healthcare Apps to 
Internet of Things (Elliott, Levin et al.). These sessions help to raise the profile of the City 
Region’s companies, facilitating direct contacts to other UK companies, universities and 
customers. 
In aiming to support and encourage entrepreneurship and enterprise, NVI Wales provides 
additional support to members in the City Region and Wales through a robust pipeline of 
business support workshops and one to one sessions.  NVI Wales has recruited a number of 
private sector companies and business support organisations as mentors to provide this 
specialist advice for its members. Topics covered by mentors include: finance, funding, 
product development, innovation, IP, marketing, and entrepreneurship. 
NVI Wales has developed and delivered a number of UK wide innovation workshops.  These 
workshops have brought together business leaders, academics and the NHS to drive 
entrepreneurship and innovation by encouraging delegates to generate and co-develop new 
ehealth solutions, ranging from healthcare apps to wearable devices. NVI Wales has thereby 
provided the Swansea City Region and ecosystem with a position in this dynamic UK wide 
digital ecosystem helping to drive and stimulate entrepreneurship, collaboration, innovation 
and business development.   
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4. Measuring: Emerging Impact  
 
4.1 ILS measurement  
Previous sections have described the challenges and opportunities to which the region is 
responding, together with activity undertaken to develop a sub-regional innovation 
system/ecosystem. The RLP research explored the nature and potential of the nascent cluster, 
while the ILS data suggest enterprises are being developed and embedded with the broader 
‘ecosystem’ around them. However, it is the sought economic contribution that is of interest 
to policy-makers and the wider community. To ascertain the scale and nature of this impact, a 
study has been undertaken examining the ILS activity for which comprehensive monitoring 
data exist. Only through such assessment can it be determined whether such interventions are 
contributing effectively.  
The economic impact of universities on their communities has long been studied (Elliott, 
Levin et al. 1988) with increasing interest in their contribution through development of 
knowledge-economies (Berman 1990, Roberts and Eesley 2009).  Huggins and Cooke (1997) 
clearly notes this in a paper analysing the economic impact of Cardiff University, with 
specific regard to linkages with the Cardiff Business & Technology Centre (though in this 
current context the Cardiff MediCentre at the Heath Hospital would be a more relevant 
linkage).   
As ILS is a publicly-funded initiative it has maintained records of its activities which can 
feed readily into evaluation. Official Government guidance for evaluation of public 
programmes and projects in the United Kingdom (including Wales) is provided by the Her 
Majesty’s Treasury Green Book (HMTreasury) This aims to provide best practice for 
appraisal and evaluation of projects of all types and sizes, covering their economic, financial, 
social and environmental aspects. 
The European Union, which co-funded ILS through Structural Funds, also offers guidance 
relating specifically to economic development initiatives in The Guide: The Evaluation of 
Socio-Economic Development ((EU 2013). This guidance provides an in-depth resource for 
the planning and undertaking of evaluations. Although it is aimed primarily at the programme 
level (that is, in consideration of multiple interrelated projects), it provides a useful resource 
for all types of evaluation. In addition, data collection for Structural Funds projects involving 
innovation activities aligns with a wider framework presented in the Oslo Manual (OECD 
2005).  
A further European Commission document, Guide to cost-benefit analysis of investment 
projects (EU 2002, EU 2014) provides specific guidance on a range of interventions 
including investments as diverse as ports and airports, museums and archaeological parks. In 
relation to ‘Industrial Estates and technological parks’, it is suggested that such interventions 
are evaluated with a time horizon of at least twenty years and that the wider social benefits, 
such as improved entrepreneurial skills are included. This is consistent with the vision of ILS 
(and the theory of cluster development), that the most significant benefits would be reaped in 
the long-term.  
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4.2 Study Approach 
The counterfactual to the ILS efforts would have simply been a region without a College of 
Medicine and the associated activities including the research that spawned new enterprises. 
However, some or different benefits may have been received by the region through other 
activities using the same initial resources. Understanding this within the complexities of a 
myriad of interventions is a challenge which also exists at Programme level (DTZ 2010).  
Using evaluation practice drawn from the Her Majesty’s Treasury Green and Magenta Books, 
the impact of ILS has been examined against the initial pump-prime European Structural 
Funds/WG investment made over relevant time horizons and a defined region. This has been 
taken as fifteen years (2004-18) and twenty years (2004-23), with the geographical area 
defined as the South West Wales region. However, as discussed earlier, it should be noted 
that initiatives of this nature are long-term endeavours and their impact would be noted over a 
horizon of decades rather than years, with impact across a wider area. Furthermore, the 
indirect impacts of the activity are important and can be considered through multiplier 
effects.  
Without sight of alternative investment opportunities available at the time, it is only possible 
to examine the cost/benefit of the intervention. This can then be given rigour by adjusting for 
timings of benefits (discounted using the 3.5% Social Time Preference Rate discount factor), 
making appropriate adjustments for deadweight, substitution and displacement, and testing 
sensitivity of assumptions.  
To focus on impact providing additionality to a region, the base scenario of this review 
applies a 50% factoring, reducing levels across all gross reported impacts. This factors 
potential effects of deadweight, displacement and substitution which may be occurring, and 
which due to inherent complexity of activities cannot be calculated otherwise. This level is in 
line with initiative (EU 2002) and programme level ex-post evaluation (WG 2012) and 
research examining current programme interventions (Oldbell3 2012).  
To support analysis of the impact, a set of scenarios have been applied ranging from 
optimistic to pessimistic, together with a base, allowing sensitivity to key assumptions to be 
assessed. This involves adjustment of key parameters as presented in Table 4;  
 Scenario 
 Low 
(Pessimistic) 
Base High 
(Optimistic) 
Adjustment reducing Outputs for 
Deadweight, Substitution and Displacement 
60% 50% 40% 
Multiplier for In-direct Employment 0.2 0.5 0.6 
Projected Combined Facility Value (Market 
Value at End of Evaluation Time Horizon) 
10,000,000 12,000,000 15,000,000 
Table 4: Cost/benefit scenarios key parameters 
 
4.3 Calculated Impact 
As described in earlier sections, the primary stated impact of ILS has been employment 
creation, delivered by levering additional investment into the region from UK and EU 
research councils, venture capitalists and other funders.  Employment creation data from the 
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Phase 1 and 2 projects, together with associated wage information and residual value of the 
project therefore provides the basis of this assessment, calculated as if benefits conclude at 
the end of the time horizon (i.e. not considering any ongoing employment).  
The activities of the ILS initiative during the Phase 2 period (2009-2015) contributing to the 
research and innovation capacity of the Welsh Life Science sector are noted in the 
independent end-project evaluation (TECC 2015), and as emanating outwards from its South 
West Wales ‘Convergence’ region hinterland.  Key outputs of the ILS initiative are noted as; 
 Assisting over 274 enterprises from micro-businesses through to multinationals  
 Contributing to the development of over 37 new pieces of intellectual property  
 Helping create 16 new enterprises  
 Supporting the creation of 510 direct jobs and scores more within the wider 
community through multiplier effects 
 Establishing a research and innovation capacity that will help sustain the regional Life 
Sciences cluster with new knowledge and skills during further phases of the initiative.    
 
The above builds upon activities undertaken during the Phase 1 period (2004-2008), during 
which 193 jobs were created, 21 collaborative projects established and 16 new enterprises 
created, alongside a new R&D facility housing industrial and academic research together 
with incubation facilities. 
  
The impact of ILS as an initiative has delivered a range of impacts across short, medium and 
long-term (ongoing) time horizons. The following analysis quantifies impacts drawn together 
under the categories of Construction Phase; Academic, R&D and Commercialisation; and 
Innovation and Enterprise benefits, as follows; 
Construction phase benefits: The impact of the project during its construction phase derived 
from employment and the creation of new facilities. This employment impact has been 
quantified from project records, using sector wage information for the region from the 
relevant periods6. In addition, the facility realised has inherent value which is a potential 
benefit (taken as projected market value) at the end of the time horizon, either to provide 
continued benefit as present, or alternative use. At the peak of construction, 57 FTE workers 
were involved in delivery of the faciltiies, across prime and subcontractors7. This represents a 
relatively minor part (8%) of the overall employment related to the ILS activity.    
This expenditure is noteworthy as it would have been a valuable contribution to the sector 
during a particularly challenging period (2009-11). Alongside the wage impacts, the 
construction activity resulted in materials expenditure with suppliers across Wales, and 
ultimately in delivery of the R&D facilities with a planned lifetime of 30+ years prior to 
refurbishment or renovation.  
Catalysing academic research, development and commercialisation:  Describing the 
economic benefits from employment within the project portfolios being led from academic 
centres. To avoid double counting, this factors solely employment and wage impacts and not 
                                                          
6 https://statswales.wales.gov.uk/Catalogue/Business-Economy-and-Labour-Market/People-and-
Work/Earnings/averageweeklyearnings-by-occupation-ukcountry 
7 Over 500 individuals in total were involved in the construction of the ILS2 facility, though the peak relates to 
the highest FTE value of individuals contracted for over twelve months by prime or subcontractors.  
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broader investments (such aas the UK Research Councils) which may include staff 
expenditure. Wage information for roles is available; however the assessment uses a lower 
value for similar roles in the wider economy, which together with adjustment for deadweight 
and displacement provides for conservative comparison. The Phase 1 project created 115 
R&D jobs, rising to 385 by the completion of Phase 2 project in June 2015. This includes 
R&D roles created to support commercialisation of research into the new ventures described 
in previous sections. The direct impact of this employment is calculated on the basis of the 
role type within the region from the time of its creation8 through to the time horizon, 
discounted accordingly.  
Supporting Innovation and Enterprise: Describing employment, enterprise and innovation 
benefits derived from wider industry-based activities established through ILS. Again, to 
avoid double counting, this category of impact includes only wage impact as other data such 
as values of investments may also include staff and expenditure outside the region. 261 full-
time roles were created which relate to this category in the period through to June 2015. 
Robust monitoring required by EU Structural Funds has clearly demonstrated that this impact 
occurred within the region, with clear relationship to the ILS actvity. 
As this employment relates to a broad range of roles (as noted in RLP research referred to 
earlier), an average regional wage during respective years for the region is used9, though the 
higher GVA per worker within the sector suggests this is a relatively conservative position. 
These same figures are used for calculation of indirect employment impact as they relate to 
the broader economy.     
Employment created with ILS assistance for each of the above categories is presented in 
Figure.6. This shows steady development over the period with the growth of research 
communities at the completion of each facility. Employment growth in the wider sector can 
be seen as tracking the development of scale in R&D.  
 
 Fig. 6 Cumulative employment growth by job type 
                                                          
8 https://statswales.wales.gov.uk/Catalogue/Business-Economy-and-Labour-Market/People-and-
Work/Earnings/averageweeklyearnings-by-occupation-ukcountry 
9 https://statswales.wales.gov.uk/Catalogue/Business-Economy-and-Labour-Market/People-and-
Work/Earnings/averageweeklyearnings-by-welshlocalareas-year 
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Using the ILS job creation and related sector wage data, the combined impact for each 
scenario was calculated, as shown in Table 5. This includes relevant adjustments for potential 
deadweight, displacement and substitution effects, with appropriate discounting of benefits. 
For all scenarios, the benefit/cost ratio shows a positive return growing across increasing time 
horizon which set against the context of weak economic growth in the broader economy is an 
encouraging position.  
 
Table. 5: Benefits and costs by scenario 
Many economic development interventions involve purely revenue activities and do not 
create facilities. Exclusion of facility value from this analysis provides positive returns, 
resulting in benefit/cost ratios of 1.94, 2.94 and 3.73 by Low, Base and High scenarios at the 
15 year time horizon. 
Further development associated with ILS, including the recently awarded Medical Research 
Council and Economic and Social Research Council Research Centres being incorporated 
into the ILS Data Science building will contribute further to the impact of the initiative. The 
inherent lead-time of bringing research to commercialisation and subsequent impact also 
suggests there may be further ventures resulting from research undertaken during the ILS 
Phase 1 and 2 project periods.  
The above assessment is based on no such new enterprise or additional job creation post-June 
2015, put simply, as if all employment benefit created ceases at the time horizon. However, 
as noted earlier, it should be anticipated from such initiatives that impacts are realised in the 
longer-term. This includes the enhanced capacity and activity in entrepreneurial learning, the 
recent short-term benefits of which are captured in activity to date but are intended to provide 
longer-term and wider impact beyond the ILS initiative and the considered time horzions.  
5. Conclusions  
 
This chapter has shown how South West Wales has worked to Understand, Act and Measure, 
in the development of a nascent Life Sciences and Health cluster. Core to this has been the 
development of an entrepreneurial learning environment drawing together academic, 
industrial and clinical communities to form new ventures.  
Benefits and Costs 
£,000 
Base Low High 
15yr 20yr 15yr 20yr 15yr 20yr 
Direct Employment 91,287 150,431 73,030 120,345 109,544 180,517 
Indirect Employment 37,294 61,607 11,934 19,714 53,704 88,714 
Combined Employment 128,581 212,038 84,964 140,059 163,248 269,231 
Combined (Discounted) 111,472 167,901 73,664 110,917 141,524 213,184 
Facility Value 12,000 12,000 10,000 10,000 15,000 15,000 
Investment PV 37,900 37,900 37,900 37,900 37,900 37,900 
       
Net Present Value 85,572 142,001 45,764 83,017 118,624 190,284 
Benefit/Cost Ratio 3.26 4.75 2.21 3.19 4.13 6.02 
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The Understanding developed through the RLP research and Life Science Exchange has 
informed a range of activities aimed to align with the absorptive capacity of the region and 
provide additionality in economic impact, primarily through new employment opportunities. 
These exercises underscored the importance of a focus upon the development of a sustainable 
pipeline of opportunities, and alignment with the broader private sector to support venture 
development. The range of skills requirements noted by surveyed firms, along with the 
commercialisation challenges and opportunities faced by scientists and entrepreneurs have 
highlighted the importance of the entrepreneurial learning environment in realising value. 
The exercises also identified the specific segments where effort could be concentrated to 
align optimally with absorptive capacity and future development, which were smart 
specialisation areas including medical devices and ehealth technologies. Importantly, this 
understanding has helped inform a coherent integrated set of regional actions, enhancing 
research capacity, commercialisation capability and skills development to optimise absorptive 
capacity. The Talent Bank concept which emerged from this work exemplifies the long-term 
systematic approach, with lifelong learning embedded in an environment spanning from 16-
18 year old student delivery though to continuing professional development. Integrated with 
higher education provision, Health Board delivery and industrial activity, Talent Bank 
expands the ILS entrepreneurial learning environment to a broader set of participants than 
those involved in previous phases.  
ILS Acting across a broad cluster or ecosystem of activity has shown the required breadth of 
engagement noted above. The focus upon medical devices, and other related fields aligns 
with the Smart Specialisation approach described by Morgan (2013) and addresses the 
limitations of previous regional initiatives with regard to absorptive capacity and focus. It 
also means that ILS complements, rather than competes, with other regional work undertaken 
by colleagues in Cardiff University contributing other strengths to the sector. Indeed, this 
clearly manifests itself in the collaboration established between the two institutions through 
the Welsh Wound Innovation Centre (WWIC) at Llantristant which is built upon the further 
smart specialisation of wound healing.  
The nature and activities of companies in and around ILS demonstrate the  characteristics of a 
Sub-Regional Innovation System as proposed by Abbey, Davies et al. (2008).  For example, 
the relationships already being established between ILS technology start-ups and 
manufacturing within the region demonstrate a contribution to broader embeddedness of 
enterprise and employment, beyond the core sector. As the number of such collaborations is 
growing, this suggests effective entrepreneurial learning is occurring amongst companies. In 
parallel, engagement through broader networks such as NVI Wales to wider UK, and LEAD 
Wales across sectors demonstrates externality and breadth to this learning.  
Measuring the impact of the initiative has helped understand the effect it has had upon the 
regional sector and broader econmy, and informs its ongoing development and delivery. 
Robust collection of project data for monitoring and evaluation by funders has supported this 
exercise, highlighting the wider impact of the ILS entrepreneurial learning environment. 
While the intellectual focus of ILS may be in buildings at Swansea University, the impact 
discovered is distributed across the region and further sectors.   
Sensitivity analysis undertaken in the assessment suggests a robust performance over the past 
decade. Even in the scenario involving combined pessimistic assumptions, it is shown that 
Page 21 of 23 
 
the contribution to the regional economy is meaningful. The analysis has also shown that a 
decade of continued effort, without being knocked off focus by columnist commentators or 
political impatience, has allowed meangingful impact to be achieved from what are 
inherently long-term endeavours.  
Furthermore, this chapter shows that ILS has embraced the most important lesson from 
(Morgan 2013) showing that Wales can learn from experience, with an approach to 
committed smart specialisation focused on a collective endeavour for innovation and regional 
economic development. ILS has therefore focused on development of activity and dealflow 
for the sector, aligned with and remaining in step with the region’s growing absorptive 
capacity. This has been underpinned by entrepreneurial learning benefitting individual 
enterpreneurs, enterprises and the partnership itself.  
The above learning has been embedded in the the recently-developed ARCH (A Regional 
Collaboration for Health) initiative which aims to extend the ILS entrepreneurial learning 
environment across the region from its origin in Swansea. Through actions such as Talent 
Bank, NVI Wales and the Life Sciences Hub, this environment will not only expand 
geographically but also extend its reach across generations and economic sectors providing a 
regional platform for lifelong entrprepreneurial learning.  
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